UK markets close in 3 hours 1 minute

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
150.57-1.39 (-0.91%)
At close: 04:03PM EDT
150.63 +0.06 (+0.04%)
Pre-market: 08:22AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close151.96
Bid150.48 x 900
Ask0.00 x 900
Day's range150.39 - 153.07
52-week range105.56 - 175.91
Avg. volume7,381,880
Market cap266.074B
Beta (5Y monthly)0.81
PE ratio (TTM)21.60
EPS (TTM)6.97
Earnings date28 Jul 2022 - 01 Aug 2022
Forward dividend & yield5.64 (3.71%)
Ex-dividend date14 Apr 2022
1y target est164.45
  • Zacks

    Amgen (AMGN) Ahead of Industry This Year So Far: What's Next?

    Amgen's (AMGN) key drugs like Prolia, Repatha, Xgeva and biosimilars are driving sales. Amgen is also rapidly advancing its robust pipeline of early and late-stage assets.

  • Motley Fool

    3 Healthcare Stocks You Can Buy and Hold for the Next Decade

    You know that you can count on them for leadership in their market and earnings growth. Here, I'll focus on three companies that stand out for their strong market positions: a biotech company and a medical device company that each dominate their fields, and a pharmaceutical player on the way to winning in market share. Vertex Pharmaceuticals (NASDAQ: VRTX) is the worldwide leader in cystic fibrosis (CF) treatment.

  • Zacks

    SpringWorks (SWTX) Down Despite Desmoid Tumors Study Meeting Goal

    SpringWorks' (SWTX) phase III study evaluating its investigational candidate, nirogacestat, in adult patients with progressing desmoid tumors, meets primary and key secondary endpoints.